Terms: = Kidney tumors AND SLC34A2, ENSG00000157765, O95436, NPTIIb, NAPI-IIb, NAPI-3B, FLJ90534, 10568
4 results:
1. Clinical aspects of the phosphate transporters NaPi-IIa and napi-iib: mutations and disease associations.
Lederer E; Wagner CA
Pflugers Arch; 2019 Jan; 471(1):137-148. PubMed ID: 30542787
[TBL] [Abstract] [Full Text] [Related]
2. Intrinsic gene changes determine the successful establishment of stable renal cancer cell lines from tumor tissue.
Feng H; Zhang Y; Liu K; Zhu Y; Yang Z; Zhang X; Liu Y
Int J Cancer; 2017 Jun; 140(11):2526-2534. PubMed ID: 28256713
[TBL] [Abstract] [Full Text] [Related]
3. Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
Fisher KE; Yin-Goen Q; Alexis D; Sirintrapun JS; Harrison W; Benjamin Isett R; Rossi MR; Moreno CS; Young AN; Osunkoya AO
Mod Pathol; 2014 Feb; 27(2):222-30. PubMed ID: 23887297
[TBL] [Abstract] [Full Text] [Related]
4. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.
Ricketts CJ; Morris MR; Gentle D; Brown M; Wake N; Woodward ER; Clarke N; Latif F; Maher ER
Epigenetics; 2012 Mar; 7(3):278-90. PubMed ID: 22430804
[TBL] [Abstract] [Full Text] [Related]
